ABSTRACT
Nanotechnology is an important field in the 21st century. Due to the size and nature of particles that it deals with, it has become indispensable in the medical field. Over the years, nanomaterials have been leveraged to treat and prevent various communicable and non-communicable diseases. Coupled with emerging associative technologies like artificial intelligence and machine learning, there is no bound to what nanomedicine can achieve. However, numerous clinical and regulatory aspects also need to be addressed. The present work highlights the clinical perspective of the current state of nanomaterials used in the medical field.
